CN103585444A - Adjuvant pharmaceutical composition for treating goiter - Google Patents

Adjuvant pharmaceutical composition for treating goiter Download PDF

Info

Publication number
CN103585444A
CN103585444A CN201310570358.3A CN201310570358A CN103585444A CN 103585444 A CN103585444 A CN 103585444A CN 201310570358 A CN201310570358 A CN 201310570358A CN 103585444 A CN103585444 A CN 103585444A
Authority
CN
China
Prior art keywords
grams
radix
pharmaceutical composition
thyromegaly
adjuvant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201310570358.3A
Other languages
Chinese (zh)
Inventor
钱家美
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201310570358.3A priority Critical patent/CN103585444A/en
Publication of CN103585444A publication Critical patent/CN103585444A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses adjuvant pharmaceutical composition for treating goiter. The adjuvant pharmaceutical composition is prepared by semen brassicae, selfheal, radix ophiopogonis, radix scrophulariae, pinellia ternata, radix pseudostellariae, astragalus and roots of red-rooted salvia in a certain weight ratio. The adjuvant pharmaceutical composition has functions of inducing diuresis to alleviate edema, eliminating toxin and promoting tissue regeneration, and is used for adjuvant therapy of the goiter, good in effect and high in safety.

Description

A kind of ancillary drug compositions for the treatment of thyromegaly
Background technology
Thyroid disease onset is slow, and its outstanding clinical manifestation is thyromegaly, is generally moderate anthorisma, and matter is tough or harder, also can be the symptoms such as nodositas, has greatly affected patient's physical and mental health.Nowadays, along with the change of rhythm of life, operating pressure strengthens and excessive iodine is taken in, and causes its sickness rate soaring year by year.Because the pathogeny of primary disease is not clear so far, existing oneself causes the great attention of the world of medicine and relevant departments.
Chinese medicine and doctor trained in Western medicine are having significant progress aspect treatment thyromegaly in recent years, but after having patient to take, breathe hard, the symptom such as unable occurs, makes patient be not easy to adhere to treatment.
Summary of the invention
The technical problem to be solved of invention is to provide a kind of effectively pharmaceutical composition of auxiliary treatment thyromegaly, use this pharmaceutical composition, can effectively treat breathing hard of occurring, the symptom such as unable when taking the medicine for the treatment of thyromegaly, effective, safe.
For solving the problems of the technologies described above, the invention provides a kind of ancillary drug compositions for the treatment of thyromegaly, it is to be made by the crude drug in following weight range: 10-20 grams of Semen Sinapis Albaes, 10-20 grams of Spica Prunellaes, 8-15 grams of Radix Ophiopogonis, 10-20 grams of Radix Scrophulariaes, 8-15 grams of the Rhizoma Pinelliaes, 10-20 grams of Radix Pseudostellariaes, 25-35 grams of the Radixs Astragali, 10-20 grams of Radix Salviae Miltiorrhizaes.
As optimization, the ancillary drug compositions of described treatment thyromegaly is made by the crude drug in following weight range: 15 grams of Semen Sinapis Albaes, 15 grams of Spica Prunellaes, 10 grams of Radix Ophiopogonis, 15 grams of Radix Scrophulariaes, 10 grams of the Rhizoma Pinelliaes, 15 grams of Radix Pseudostellariaes, 30 grams of the Radixs Astragali, 15 grams of Radix Salviae Miltiorrhizaes.
Ancillary drug compositions of the present invention selects Semen Sinapis Albae, Spica Prunellae, Radix Ophiopogonis, Radix Scrophulariae, the Rhizoma Pinelliae, Radix Pseudostellariae, the Radix Astragali, Radix Salviae Miltiorrhizae to combine, by these drug regimens, make each efficacy of drugs produce synergism, thus effective auxiliary treatment thyromegaly.
Semen Sinapis Albae, nature and flavor are pungent, and temperature is nontoxic, enters lung, liver, spleen, stomach, pericardium channel, has promoting the circulation of QI eliminating phlegm, and the function of reducing swelling and alleviating pain is controlled phlegm retention cough with asthma, fullness and distention in the chest and hypochondrium pain, regurgitation vomiting, aphasia due to apoplexy, limbs arthralgia pain is numb, beriberi, carbuncle of yin nature, toxic swelling, treating swelling and pain by traumatic injury.
Spica Prunellae, nature and flavor bitter, acrid, cold.Enter liver, gallbladder meridian, have the function of liver heat removing, eliminating stagnation, diuresis, control the effects such as pestilence, acute mastitis, ophthalmalgia, jaundice, gonorrhea, hypertension.
Radix Ophiopogonis, property sweet and slightly bitter taste, cold, enter lung, stomach, heart channel, there is nourishing YIN and moistening the lung, the relieving restlessness that clears away heart-fire, the function of reinforcing stomach reg fluid, controls dryness of the lung dry cough, spits blood, spitting of blood, consumptive lung disease, lung abscess, asthenia dysphoria with smothery sensation, thirsty clearly, calentura Tianjin wound, dry mouth and throat, constipation.
Radix Scrophulariae, nature and flavor are bitter salty cool, have YIN nourishing, pathogenic fire reducing, relieving restlessness, the function of removing toxic substances, controls calentura excessive thirst, laryngopharynx swelling and pain, carbuncle scrofula.
The Rhizoma Pinelliae, nature and flavor are pungent, and temperature is poisonous, enters spleen, stomach warp, has drying dampness to eliminate phlegm, stopping nausea and vomiting by lowering the adverse flow of QI, the function of dissolving lump and resolving mass, controls damp-phlegm cold drink, vomiting, regurgitation, cough with asthma abundant expectoration, chest and diaphragm distension, syncope due to accumulation of phlegm headache, dizzy sleeplessness, outer subduing inflammation.
Radix Pseudostellariae, nature and flavor sweetness and bitterness, tepor, enters the heart, spleen, lung three warps, has the function of tonifying the lung, spleen invigorating, controls cough due to deficiency of the lung, insufficiency of the spleen lack of appetite, cardiopalmus and antiperspirant, spirit is tired.
The Radix Astragali, nature and flavor are sweet, and tepor enters lung, spleen channel, raw with the useful consolidating superficial resistance of defending, inducing diuresis to remove edema, poison holding, the function of granulation promoting, controls spontaneous perspiration, night sweat, arthralgia due to stagnation of blood, edema, carbuncle is not burst or is burst and hold back for a long time; Process by the function that has invigorating the spleen and replenishing QI, control internal injury overstrain, diarrhea due to hypofunction of the spleen, proctoptosis, deficiency of vital energy blood prostration, the disease of metrorrhagia and leukorrhagia and all weakness of QI blood deficiency.
Radix Salviae Miltiorrhizae, nature and flavor are bitter, and tepor, enters the heart, Liver Channel, has blood circulation and promoting silt, calming heart and tranquilizing mind, evacuation of pus, the function of pain relieving, controls angina cordis, menoxenia, dysmenorrhea, to close, metrorrhagia leukorrhagia, leprosy abdominal mass, gathers, abdominal pain due to blood stasis, arthralgia, palpitation with fear sleeplessness, malignant boil toxic swelling.
Ancillary drug compositions of the present invention has the function that benefit is defended consolidating superficial resistance, inducing diuresis to remove edema, promoting the production of body fluid and benefiting QI, for auxiliary treatment thyromegaly, can effectively treat breathing hard of occurring, the symptom such as unable when taking the medicine for the treatment of thyromegaly, effective, safe, human body is not had to harm.
The preparation method of ancillary drug compositions that the present invention treats thyromegaly is simple, by each medicine of described weight proportion put into the container of boiling medicine add water routinely the decocting method of Chinese medicine decoct,, morning and evening every day takes for twice.
The specific embodiment
By test example, further set forth ancillary drug compositions of the present invention below.
The ancillary drug compositions for the treatment of thyromegaly, is made by the crude drug in following weight range: 15 grams of Semen Sinapis Albaes, 15 grams of Spica Prunellaes, 10 grams of Radix Ophiopogonis, 15 grams of Radix Scrophulariaes, 10 grams of the Rhizoma Pinelliaes, 15 grams of Radix Pseudostellariaes, 30 grams of the Radixs Astragali, 15 grams of Radix Salviae Miltiorrhizaes.
After decocting according to conventional decocting for Chinese herbal medicine method, to patient, sooner or later take.
By ancillary drug compositions auxiliary treatment thyromegaly patient of the present invention 50 examples, wherein 30 examples are carried out conventional therapy, 20 examples by doctor's advice treatment by Chinese herbs by doctor's advice with Western medicine, result is not to taking effective 38 examples of improvement of breathing hard of occurring before the present invention, the symptom such as unable, 10 examples take a turn for the better, invalid 2 examples, obvious effective rate 76%, improvement rate 20%, total effective rate is 96%, illustrate that the present invention has good promotional value, can help patient to remove misery, the treatment of thyromegaly can be carried through to the end, for curing thyromegaly, provide effective assurance.

Claims (2)

1. an ancillary drug compositions for the treatment of thyromegaly, is characterized in that: it is to be made by the crude drug in following weight range: 10-20 grams of Semen Sinapis Albaes, 10-20 grams of Spica Prunellaes, 8-15 grams of Radix Ophiopogonis, 10-20 grams of Radix Scrophulariaes, 8-15 grams of the Rhizoma Pinelliaes, 10-20 grams of Radix Pseudostellariaes, 25-35 grams of the Radixs Astragali, 10-20 grams of Radix Salviae Miltiorrhizaes.
2. the ancillary drug compositions for the treatment of thyromegaly according to claim 1, is characterized in that: it is to be made by the crude drug in following weight range: 15 grams of Semen Sinapis Albaes, 15 grams of Spica Prunellaes, 10 grams of Radix Ophiopogonis, 15 grams of Radix Scrophulariaes, 10 grams of the Rhizoma Pinelliaes, 15 grams of Radix Pseudostellariaes, 30 grams of the Radixs Astragali, 15 grams of Radix Salviae Miltiorrhizaes.
CN201310570358.3A 2013-11-17 2013-11-17 Adjuvant pharmaceutical composition for treating goiter Pending CN103585444A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201310570358.3A CN103585444A (en) 2013-11-17 2013-11-17 Adjuvant pharmaceutical composition for treating goiter

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201310570358.3A CN103585444A (en) 2013-11-17 2013-11-17 Adjuvant pharmaceutical composition for treating goiter

Publications (1)

Publication Number Publication Date
CN103585444A true CN103585444A (en) 2014-02-19

Family

ID=50075897

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201310570358.3A Pending CN103585444A (en) 2013-11-17 2013-11-17 Adjuvant pharmaceutical composition for treating goiter

Country Status (1)

Country Link
CN (1) CN103585444A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112316031A (en) * 2020-12-04 2021-02-05 玉林市卫生学校附属医院 Composition for treating hypothyroidism

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
胡齐鸣等: "徐蓉娟治疗甲状腺疾病经验", 《辽宁中医杂志》 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112316031A (en) * 2020-12-04 2021-02-05 玉林市卫生学校附属医院 Composition for treating hypothyroidism

Similar Documents

Publication Publication Date Title
CN102423402B (en) Traditional Chinese drug composition for treating night sweat
CN103536758B (en) Traditional Chinese medicinal composition for treating night sweat due to yin deficiency
CN103055116B (en) Traditional Chinese medicine composition for treating acnes
CN104984316A (en) Medicine for treating female cold in uterus
CN103432390A (en) Medicament for treating coronary heart disease and preparation method thereof
CN103349757A (en) Traditional Chinese medicine composition for treating fire excess from yin deficiency
CN105535390A (en) Traditional Chinese medicine decoction for treating coronary heart disease and preparation method of traditional Chinese medicine decoction
CN101095828A (en) Chinese traditional medicine composition for treating diabetes constipation
CN103330854B (en) Traditional Chinese medicine composition for treating nasal hemorrhage
CN103041271B (en) Traditional Chinese medicine composition for treating emphysema
CN101780220B (en) Traditional Chinese medicine for treating chronic gastritis
CN101129841A (en) Traditional Chinese medicine composition for treating self-output of latex
CN103816366B (en) A kind of medicine treating oral ulcer
CN103585444A (en) Adjuvant pharmaceutical composition for treating goiter
CN103110911B (en) Traditional Chinese medicine composition for treating coronary heart disease
CN104547369A (en) Oral medicine for treating blepharospasm and preparation method thereof
CN101085313A (en) Traditional Chinese medicine preparation for treating vicarious menstruation
CN103330814A (en) Traditional Chinese medicine composition for treating deficiency of kidney yang
CN103432544B (en) Decoction for treating upper gastrointestinal hemorrhage
CN102772723A (en) Chinese medicinal prescription for treating phthisis
CN102406879A (en) Chinese medicine composition for treating rhinitis
CN101912488A (en) Chinese medicinal herb for treating hypomenorrhea
CN106620359A (en) Medicine for treating acute nephritis and preparation method thereof
CN105816603A (en) Traditional Chinese medicine composition for treating postpartum hemorrhage
CN105106759A (en) Orally-taken medicine for treating psoriasis and preparation method thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20140219